Irene Torres-Moreno
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Prevalence of Anisakiasis in Madrid (Spain) after 20 Years of Preventive Legislation.
Journal: Pathogens (Basel, Switzerland)
Published: July 31, 2024
Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation.
Journal: International journal of molecular sciences
Published: December 22, 2023
Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients.
Journal: Frontiers in immunology
Published: April 21, 2023
Vaccination against SARS-CoV-2 in patients with multiple sclerosis
Journal: Revista de neurologia
Published: March 25, 2021
SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 05, 2021
Risk and outcomes of COVID-19 in patients with multiple sclerosis.
Journal: European journal of neurology
Published: December 21, 2020
EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic
Journal: Revista de neurologia
Published: April 25, 2020
Immunophenotype and Transcriptome Profile of Patients With Multiple Sclerosis Treated With Fingolimod: Setting Up a Model for Prediction of Response in a 2-Year Translational Study.
Journal: Frontiers in immunology
Published: February 13, 2018
Anti-CD20 monoclonal antibodies in multiple sclerosis.
Journal: Expert review of neurotherapeutics
Published: October 11, 2016
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Journal: Expert review of neurotherapeutics
Published: October 22, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026